Paré, Guillaume <br/><br/>
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.  [electronic resource] 

 -  Circulation. Cardiovascular genetics  Apr 2012 
 - 250-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1942-3268 
<br/><br/><label>Standard No.: </label>10.1161/CIRCGENETICS.111.961417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angina, Unstable--complications<br/>Aryldialkylphosphatase--genetics<br/>Atrial Fibrillation--drug therapy<br/>Clopidogrel<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Risk Factors<br/>Ticlopidine--analogs & derivatives